MedImmune

FluMist Quadrivalent (2021/2022)

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

MedImmune

Flumist Quadrivalent (2021/2022) HCPCS:

90672

HCPCS Code Descriptor:

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

Category:

CPT Drug Code

Flumist Quadrivalent (2021/2022) NDCs:

66019-0310-10

Primary Type:

Vaccine-Flu

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Nasal

Flumist Quadrivalent (2021/2022) CPT Codes:

Potential CPT administration codes for Flumist Quadrivalent (2021/2022) can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

66019-0310-10

About Flumist Quadrivalent (2021/2022):

FluMist Quadrivalent (2021/2022) is a Vaccine-Flu drug manufactured by MedImmune and administered via the Nasal route of administration. The CPT Drug Code: 90672 is aligned to the drug FluMist Quadrivalent (2021/2022).

ACCESS PRICING AND MORE BY REGISTERING

90672 Added Date:

NA

90672 Effective Date:

NA

90672 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Flumist Quadrivalent (2021/2022) billing and coding information.
Our team did not identify a source for Flumist Quadrivalent (2021/2022) patient assistance information. Please reach out to our team if you feel that this is a mistake.
FluMist Quadrivalent (2021/2022) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for FluMist Quadrivalent (2021/2022). Please check back in a few weeks.